John V. Oyler, Founder, Chairman and CEO at BeOne Medicines, shared a post on LinkedIn:
“At BeOne Medicines, we believe Cancer Has No Borders, and Neither Do We.
That’s why we brought nearly 100 patient advocates together at ASH2025 for our AI Innovation Lab, to explore how AI can transform the blood cancer patient journey.
While there, we learned:
1) Patients are already turning to AI – we need to meet them there.
A story was shared about a blood cancer patient who uploaded scan results into AI before speaking to a doctor. The information received was inaccurate and almost a decade old. So, while the tools still need to improve, we can’t wait for that happen: patients are already using AI, and the broader cancer community must help them navigate it safely with trustworthy information.
2) We’re witnessing a fundamental shift: patients are becoming CEOs of their own health.
Data Deloitte shared shows 51% of patients are willing to tell their doctors they disagree, up from single digits just years ago. This shift does not undermine clinical expertise – it reflects patients’ growing desire to participate actively in decisions about their care. For all of us, this means ensuring patients have clearer information and tools that help them make confident decisions with their clinicians.
3) AI + human judgment is where the real power lies.
The cancer journey is deeply human – and AI can’t change that. It’s not here to replace human judgment or compassion, but when developed responsibly and grounded in trusted data, AI can amplify human expertise, enhance decision-making, and help care teams deliver more informed, compassionate, and connected care.
What’s next?
This was the first conversation of many. We’re going to continue this work with patients, advocates, clinicians, and partners across the cancer community to shape AI-enabled tools that:
- accelerate blood cancer education
- improve data integrity and access to trusted information
- make care more personal and human
Thank you to our event speakers Michele Nadeem-Baker, Meghan Gutierrez, Neal Batra and Thomas Yan, our own Eleanor K. Duff, PhD, Matthew Shaulis, Josh Schwartz, Michael Schoen, Anand Reddi, Mark Riedl, Jennifer Branstetter, and every advocate who challenged us to think differently.
Together, we are how the world stops cancer.”
Proceed to the video attached to the post.
More posts featuring John V. Oyler.